MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gb Sciences Inc (OP:GBLX)

0.0003 UNCHANGED
Streaming Delayed Price Updated: 3:46 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,623
Open 0.0003
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0003
Today's Range 0.0003 - 0.0003
52wk Range 0.0001 - 0.0085
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Cannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday ↗
Discover 10 science-backed cannabis benefits for Thanksgiving, from reducing stress to boosting appetite, mood, and sleep quality. 
Via Benzinga
Topics Cannabis
News headline image
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences
Via ACCESSWIRE

Performance

YTD
-40.0%
-40.0%
1 Month
N/A
N/A
3 Month
-25.0%
-25.0%
6 Month
+50.0%
+50.0%
1 Year
-91.9%
-91.9%

More News

Read More
News headline image
Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)
Via ACCESSWIRE
News headline image
Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge
Via ACCESSWIRE
News headline image
GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China
Via ACCESSWIRE
News headline image
Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform
Via ACCESSWIRE
News headline image
Marijuana And Chronic Pain: Gb Sciences' Nanoparticle Technology Boosts Efficacy Of Cannabis Terpenes ↗
Via Benzinga
News headline image
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
Via Newswire.com
Topics Death
News headline image
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform
From Gb Sciences
Via GlobeNewswire
News headline image
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
Via Newswire.com
News headline image
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations
From Gb Sciences
Via GlobeNewswire
News headline image
Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study ↗
Via Benzinga
News headline image
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
Via Newswire.com
Topics Cannabis
News headline image
Gb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal Study
Via Newswire.com
News headline image
TODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 Conference
Via Newswire.com
Topics Cannabis
News headline image
New Study Shows Promising Results In Treatment Of Parkinson's Disease With Cannabinoids ↗
Via Benzinga
News headline image
Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's Disease
Via Newswire.com
Topics Cannabis
News headline image
TODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal Article
Via Newswire.com
Topics Cannabis
News headline image
TODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit
Via Newswire.com
Topics Intellectual Property
News headline image
TODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform Summit
Via Newswire.com
Topics Intellectual Property
News headline image
TODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics Conference
Via Newswire.com
News headline image
FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies
Via Newswire.com
News headline image
Gb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's Disease ↗
Via Benzinga
News headline image
Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge
Via Newswire.com
Topics Intellectual Property
News headline image
Gb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research Article
Via Newswire.com

Frequently Asked Questions

Is Gb Sciences Inc publicly traded?
Yes, Gb Sciences Inc is publicly traded.
What exchange does Gb Sciences Inc trade on?
Gb Sciences Inc trades on the OTC Traded
What is the ticker symbol for Gb Sciences Inc?
The ticker symbol for Gb Sciences Inc is GBLX on the OTC Traded
What is the current price of Gb Sciences Inc?
The current price of Gb Sciences Inc is 0.0003
When was Gb Sciences Inc last traded?
The last trade of Gb Sciences Inc was at 02/17/26 03:46 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story